Do analysts prefer ACB or OGI?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aurora Cannabis 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.50 Organigram Global 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33

Do analysts recommend OGI or CGC?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Organigram Global 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33 Canopy Growth 1 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.20

Do analysts recommend OGI or CRON?

Cronos Group has a consensus target price of $2.30, suggesting a potential downside of 26.75%. Given Cronos Group's stronger consensus rating and higher probable upside, analysts clearly believe Cronos Group is more favorable than Organigram Global. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Organigram Global 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33 Cronos Group 0 Sell rating(s) 3 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.40

Do analysts prefer OGI or SNDL?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Organigram Global 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33 SNDL 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Which has better valuation and earnings, OGI or SNDL?

SNDL has higher revenue and earnings than Organigram Global. SNDL is trading at a lower price-to-earnings ratio than Organigram Global, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Organigram Global $185.07M 0.80 -$17.70M $0.46 2.28 SNDL $928.39M 0.37 -$11.29M -$0.06 N/A

Is OGI or SNDL more profitable?

Organigram Global has a net margin of 28.14% compared to SNDL's net margin of -2.36%. SNDL's return on equity of -2.01% beat Organigram Global's return on equity. Company Net Margins Return on Equity Return on Assets Organigram Global 28.14% -13.39% -8.67% SNDL -2.36% -2.01% -1.67%

Do analysts rate TLRY or OGI?

Tilray Brands currently has a consensus target price of $8.00, suggesting a potential upside of 99.00%. Given Tilray Brands' stronger consensus rating and higher possible upside, analysts plainly believe Tilray Brands is more favorable than Organigram Global. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tilray Brands 1 Sell rating(s) 3 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 2.43 Organigram Global 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33

Organigram Global (OGI) Competitors

$1.05 -0.02 (-1.87%)

Closing price 09/11/2026 04:00 PM Eastern

Extended Trading

$1.04 -0.01 (-1.33%)

As of 09/11/2026 07:52 PM Eastern

Compare

OGI vs. ACB, CGC, CRON, SNDL, and TLRY

Should you buy Organigram Global stock or one of its competitors? Organigram Global's main competitors and comparable companies include Aurora Cannabis (ACB), Canopy Growth (CGC), Cronos Group (CRON), SNDL (SNDL), and Tilray Brands (TLRY). Companies are selected based on similarities in market, industry, and size.

How does Organigram Global compare to Aurora Cannabis?

Aurora Cannabis (NASDAQ:ACB) and Organigram Global (NASDAQ:OGI) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, valuation, institutional ownership, earnings, media sentiment, dividends, profitability and analyst recommendations.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aurora Cannabis	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50
Organigram Global	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

In the previous week, Aurora Cannabis had 4 more articles in the media than Organigram Global. MarketBeat recorded 5 mentions for Aurora Cannabis and 1 mentions for Organigram Global. Organigram Global's average media sentiment score of 1.87 beat Aurora Cannabis' score of 0.49 indicating that Organigram Global is being referred to more favorably in the news media.

Company	Overall Sentiment
Aurora Cannabis	Neutral
Organigram Global	Very Positive

Aurora Cannabis has a beta of 0.63, meaning that its stock price is 37% less volatile than the broader market. Comparatively, Organigram Global has a beta of 1.49, meaning that its stock price is 49% more volatile than the broader market.

47.6% of Aurora Cannabis shares are held by institutional investors. Comparatively, 34.6% of Organigram Global shares are held by institutional investors. 0.0% of Aurora Cannabis shares are held by company insiders. Comparatively, 0.1% of Organigram Global shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Organigram Global has a net margin of 28.14% compared to Aurora Cannabis' net margin of -32.26%. Aurora Cannabis' return on equity of 4.37% beat Organigram Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aurora Cannabis	-32.26%	4.37%	3.45%
Organigram Global	28.14%	-13.39%	-8.67%

Organigram Global has lower revenue, but higher earnings than Aurora Cannabis. Aurora Cannabis is trading at a lower price-to-earnings ratio than Organigram Global, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aurora Cannabis	$247.82M	0.98	-$88.13M	-$1.41	N/A
Organigram Global	$185.07M	0.80	-$17.70M	$0.46	2.28

Summary

Aurora Cannabis and Organigram Global tied by winning 8 of the 16 factors compared between the two stocks.

How does Organigram Global compare to Canopy Growth?

Organigram Global (NASDAQ:OGI) and Canopy Growth (NASDAQ:CGC) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, risk, media sentiment, profitability, valuation, dividends and earnings.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Organigram Global	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Canopy Growth	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20

In the previous week, Canopy Growth had 5 more articles in the media than Organigram Global. MarketBeat recorded 6 mentions for Canopy Growth and 1 mentions for Organigram Global. Organigram Global's average media sentiment score of 1.87 beat Canopy Growth's score of 0.86 indicating that Organigram Global is being referred to more favorably in the media.

Company	Overall Sentiment
Organigram Global	Very Positive
Canopy Growth	Positive

34.6% of Organigram Global shares are owned by institutional investors. Comparatively, 3.3% of Canopy Growth shares are owned by institutional investors. 0.1% of Organigram Global shares are owned by insiders. Comparatively, 0.4% of Canopy Growth shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Organigram Global has a net margin of 28.14% compared to Canopy Growth's net margin of -65.33%. Organigram Global's return on equity of -13.39% beat Canopy Growth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Organigram Global	28.14%	-13.39%	-8.67%
Canopy Growth	-65.33%	-21.91%	-14.34%

Organigram Global has higher earnings, but lower revenue than Canopy Growth. Canopy Growth is trading at a lower price-to-earnings ratio than Organigram Global, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Organigram Global	$185.07M	0.80	-$17.70M	$0.46	2.28
Canopy Growth	$293.63M	1.42	-$190.29M	-$0.45	N/A

Organigram Global has a beta of 1.49, suggesting that its stock price is 49% more volatile than the broader market. Comparatively, Canopy Growth has a beta of 0.83, suggesting that its stock price is 17% less volatile than the broader market.

Summary

Organigram Global beats Canopy Growth on 10 of the 14 factors compared between the two stocks.

How does Organigram Global compare to Cronos Group?

Organigram Global (NASDAQ:OGI) and Cronos Group (NASDAQ:CRON) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, risk, analyst recommendations, dividends, institutional ownership, valuation, earnings and profitability.

34.6% of Organigram Global shares are held by institutional investors. Comparatively, 8.7% of Cronos Group shares are held by institutional investors. 0.1% of Organigram Global shares are held by company insiders. Comparatively, 7.8% of Cronos Group shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Organigram Global has a beta of 1.49, suggesting that its share price is 49% more volatile than the broader market. Comparatively, Cronos Group has a beta of 0.94, suggesting that its share price is 6% less volatile than the broader market.

In the previous week, Cronos Group had 1 more articles in the media than Organigram Global. MarketBeat recorded 2 mentions for Cronos Group and 1 mentions for Organigram Global. Cronos Group's average media sentiment score of 1.89 beat Organigram Global's score of 1.87 indicating that Cronos Group is being referred to more favorably in the news media.

Company	Overall Sentiment
Organigram Global	Very Positive
Cronos Group	Very Positive

Cronos Group has a consensus target price of $2.30, suggesting a potential downside of 26.75%. Given Cronos Group's stronger consensus rating and higher probable upside, analysts clearly believe Cronos Group is more favorable than Organigram Global.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Organigram Global	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Cronos Group	0 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.40

Cronos Group has lower revenue, but higher earnings than Organigram Global. Organigram Global is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Organigram Global	$185.07M	0.80	-$17.70M	$0.46	2.28
Cronos Group	$146.59M	7.89	-$9.45M	$0.20	15.70

Cronos Group has a net margin of 39.08% compared to Organigram Global's net margin of 28.14%. Cronos Group's return on equity of 4.85% beat Organigram Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Organigram Global	28.14%	-13.39%	-8.67%
Cronos Group	39.08%	4.85%	4.62%

Summary

Cronos Group beats Organigram Global on 11 of the 15 factors compared between the two stocks.

How does Organigram Global compare to SNDL?

Organigram Global (NASDAQ:OGI) and SNDL (NASDAQ:SNDL) are related small-cap companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, media sentiment, earnings, analyst recommendations, dividends, institutional ownership, valuation and risk.

In the previous week, SNDL had 3 more articles in the media than Organigram Global. MarketBeat recorded 4 mentions for SNDL and 1 mentions for Organigram Global. Organigram Global's average media sentiment score of 1.87 beat SNDL's score of 0.97 indicating that Organigram Global is being referred to more favorably in the media.

Company	Overall Sentiment
Organigram Global	Very Positive
SNDL	Positive

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Organigram Global	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
SNDL	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Organigram Global has a net margin of 28.14% compared to SNDL's net margin of -2.36%. SNDL's return on equity of -2.01% beat Organigram Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Organigram Global	28.14%	-13.39%	-8.67%
SNDL	-2.36%	-2.01%	-1.67%

SNDL has higher revenue and earnings than Organigram Global. SNDL is trading at a lower price-to-earnings ratio than Organigram Global, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Organigram Global	$185.07M	0.80	-$17.70M	$0.46	2.28
SNDL	$928.39M	0.37	-$11.29M	-$0.06	N/A

34.6% of Organigram Global shares are held by institutional investors. 0.1% of Organigram Global shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Organigram Global has a beta of 1.49, meaning that its stock price is 49% more volatile than the broader market. Comparatively, SNDL has a beta of 0.96, meaning that its stock price is 4% less volatile than the broader market.

Summary

Organigram Global beats SNDL on 10 of the 15 factors compared between the two stocks.

How does Organigram Global compare to Tilray Brands?

Tilray Brands (NASDAQ:TLRY) and Organigram Global (NASDAQ:OGI) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, earnings, dividends, media sentiment, valuation, profitability and institutional ownership.

9.4% of Tilray Brands shares are held by institutional investors. Comparatively, 34.6% of Organigram Global shares are held by institutional investors. 0.8% of Tilray Brands shares are held by insiders. Comparatively, 0.1% of Organigram Global shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Tilray Brands had 13 more articles in the media than Organigram Global. MarketBeat recorded 14 mentions for Tilray Brands and 1 mentions for Organigram Global. Organigram Global's average media sentiment score of 1.87 beat Tilray Brands' score of 0.67 indicating that Organigram Global is being referred to more favorably in the news media.

Company	Overall Sentiment
Tilray Brands	Positive
Organigram Global	Very Positive

Tilray Brands currently has a consensus target price of $8.00, suggesting a potential upside of 99.00%. Given Tilray Brands' stronger consensus rating and higher possible upside, analysts plainly believe Tilray Brands is more favorable than Organigram Global.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tilray Brands	1 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.43
Organigram Global	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

Organigram Global has a net margin of 28.14% compared to Tilray Brands' net margin of -13.11%. Tilray Brands' return on equity of -7.76% beat Organigram Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tilray Brands	-13.11%	-7.76%	-5.59%
Organigram Global	28.14%	-13.39%	-8.67%

Tilray Brands has a beta of 1.92, suggesting that its stock price is 92% more volatile than the broader market. Comparatively, Organigram Global has a beta of 1.49, suggesting that its stock price is 49% more volatile than the broader market.

Organigram Global has lower revenue, but higher earnings than Tilray Brands. Tilray Brands is trading at a lower price-to-earnings ratio than Organigram Global, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tilray Brands	$915.45M	0.60	-$121.40M	-$1.08	N/A
Organigram Global	$185.07M	0.80	-$17.70M	$0.46	2.28

Summary

Tilray Brands beats Organigram Global on 9 of the 16 factors compared between the two stocks.

Get Organigram Global News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OGI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

OGI vs. The Competition

Export

Metric	Organigram Global	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$150.88M	$5.43B	$7.16B	$12.71B
Dividend Yield	N/A	1.79%	2.56%	11.16%
P/E Ratio	2.28	24.63	272.98	25.27
Price / Sales	0.80	82.34	654.99	99.48
Price / Cash	N/A	32.53	77.04	51.44
Price / Book	0.56	5.96	10.33	6.20
Net Income	-$17.70M	$150.14M	$3.49B	$358.27M
7 Day Performance	-9.09%	-2.88%	-3.33%	-2.36%
1 Month Performance	-18.60%	-3.13%	-0.42%	-2.77%
1 Year Performance	-36.75%	9.28%	19.22%	7.64%

Organigram Global Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
OGI Organigram Global	1.7643 of 5 stars	$1.05 -1.9%	N/A	-36.7%	$150.88M	$185.07M	2.28	1,139	Positive News
ACB Aurora Cannabis	1.2008 of 5 stars	$4.05 flat	N/A	-24.1%	$262.60M	$247.82M	N/A	1,028
CGC Canopy Growth	0.9267 of 5 stars	$0.98 -2.0%	N/A	-33.3%	$438.11M	$251.01M	N/A	1,128
CRON Cronos Group	1.6735 of 5 stars	$3.38 +0.3%	$2.30 -32.0%	+21.7%	$1.25B	$146.59M	16.90	450	Positive News Analyst Downgrade
SNDL SNDL	1.5866 of 5 stars	$1.36 -0.7%	$5.00 +267.6%	-43.9%	$350.06M	$677.32M	N/A	2,751	Positive News Options Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:OGI) was last updated on 9/12/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Organigram Global (OGI) Competitors

OGI vs. ACB, CGC, CRON, SNDL, and TLRY

How does Organigram Global compare to Aurora Cannabis?

Summary

How does Organigram Global compare to Canopy Growth?

Summary

How does Organigram Global compare to Cronos Group?

Summary

How does Organigram Global compare to SNDL?

Summary

How does Organigram Global compare to Tilray Brands?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

OGI vs. The Competition

Organigram Global Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Organigram Global (OGI) Competitors

OGI vs. ACB, CGC, CRON, SNDL, and TLRY

How does Organigram Global compare to Aurora Cannabis?

Do analysts prefer ACB or OGI?

Does the media refer more to ACB or OGI?

Which has more volatility and risk, ACB or OGI?

Do institutionals and insiders believe in ACB or OGI?

Is ACB or OGI more profitable?

Which has higher earnings and valuation, ACB or OGI?

Summary

How does Organigram Global compare to Canopy Growth?

Do analysts recommend OGI or CGC?

Does the media prefer OGI or CGC?

Do institutionals & insiders have more ownership in OGI or CGC?

Is OGI or CGC more profitable?

Which has stronger valuation & earnings, OGI or CGC?

Which has more risk and volatility, OGI or CGC?

Summary

How does Organigram Global compare to Cronos Group?

Do institutionals & insiders hold more shares of OGI or CRON?

Which has more volatility and risk, OGI or CRON?

Does the media prefer OGI or CRON?

Do analysts recommend OGI or CRON?

Which has stronger earnings & valuation, OGI or CRON?

Is OGI or CRON more profitable?

Summary

How does Organigram Global compare to SNDL?

Does the media prefer OGI or SNDL?

Do analysts prefer OGI or SNDL?

Is OGI or SNDL more profitable?

Which has better valuation and earnings, OGI or SNDL?

Do institutionals and insiders hold more shares of OGI or SNDL?

Which has more risk and volatility, OGI or SNDL?

Summary

How does Organigram Global compare to Tilray Brands?

Do institutionals and insiders have more ownership in TLRY or OGI?

Does the media refer more to TLRY or OGI?

Do analysts rate TLRY or OGI?

Is TLRY or OGI more profitable?

Which has more risk and volatility, TLRY or OGI?

Which has better earnings & valuation, TLRY or OGI?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

OGI vs. The Competition

Organigram Global Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools